Martha A. Alexander‐Miller

Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.

Martha A. Alexander‐Miller, Graham R. Leggatt, J A Berzofsky · Proceedings of the National Academy of Sciences · 1996 · 507 citations · Full text

Life Sciences, Immunology, Adaptive Immunity +16

Target Cell Lysis by CTL Granule Exocytosis Is Independent of ICE/Ced-3 Family Proteases

Apurva Sarin, Mark S. Williams, Martha A. Alexander‐Miller et al. · Immunity · 1997 · 229 citations · Full text

Life Sciences, Cell Biology, Immunology +12

Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL.

Martha A. Alexander‐Miller, Graham R. Leggatt, Apurva Sarin et al. · The Journal of Experimental Medicine · 1996 · 221 citations · Full text

Life Sciences, Cell Biology, Immunology +17

High-Avidity CTL Exploit Two Complementary Mechanisms to Provide Better Protection Against Viral Infection Than Low-Avidity CTL

Michael A. Derby, Martha A. Alexander‐Miller, Richard Tse et al. · The Journal of Immunology · 2001 · 203 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Dissecting intratumoral myeloid cell plasticity by single cell RNA‐seq

Qianqian Song, Gregory A. Hawkins, L. James Wudel et al. · Cancer Medicine · 2019 · 176 citations · Full text

Life Sciences, Immunology, Oncology +17